Cargando…
Let-7b expression determines response to chemotherapy through the regulation of Cyclin D1 in Glioblastoma
BACKGROUND: Glioblastoma is the most common type of primary brain tumors. Cisplatin is a commonly used chemotherapeutic agent for Glioblastoma patients. Despite a consistent rate of initial responses, cisplatin treatment often develops chemoresistance, leading to therapeutic failure. Cellular resist...
Autores principales: | Guo, Yong, Yan, Kuipo, Fang, Jiasheng, Qu, Qiang, Zhou, Ming, Chen, Fenghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3716992/ https://www.ncbi.nlm.nih.gov/pubmed/23806108 http://dx.doi.org/10.1186/1756-9966-32-41 |
Ejemplares similares
-
let-7b and let-7c are determinants of intrinsic chemoresistance in renal cell carcinoma
por: Peng, Jingtao, et al.
Publicado: (2015) -
Induction of microRNA-let-7a inhibits lung adenocarcinoma cell growth by regulating cyclin D1
por: Zhao, Wei, et al.
Publicado: (2018) -
USP5 Sustains the Proliferation of Glioblastoma Through Stabilization of CyclinD1
por: Li, Gen, et al.
Publicado: (2021) -
DICER1 regulated let-7 expression levels in p53-induced cancer repression requires cyclin D1
por: Sun, Xin, et al.
Publicado: (2015) -
Hes3 Enhances the Malignant Phenotype of Lung Cancer through Upregulating Cyclin D1, Cyclin D3 and MMP7 Expression
por: Fang, Changqing, et al.
Publicado: (2019)